About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? [email protected]

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clinical EvaluatioN of TElmisartan-based Antihypertensive Regimen

NCT00613314·122 sites·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Boehringer Ingelheim

Age

45–any

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

Age \> 45 years
Increased waist circumference (\>88.9cm \[\>35in\] men, \>78.7cm \[\>31in\] for women)
Elevated triglycerides (\>150mg/dl)
Low HDL cholesterol (\<40mg/dl in men, \<50mg/dl in women)
Hypertension (\>130/\>85mmHG)
Impaired fasting glucose (\>110mg/dl) (8)
Hypertensive patient assessed to benefit from telmisartan based treatment

You may not be if

Hypersensitivity to telmisartan, hydrochlorothiazide (HCTZ) and its excipients
\<3 months myocardial infarction (MI), stroke or severe heart failure

The record

StatusCompleted

PhaseNo phase

Taking part15,268

StartedJun 2007

UpdatedMay 26, 2014

Conditions

Hypertension Metabolic Syndrome X

Where122

Boehringer Ingelheim Investigational Site
Alaminos City, Pangasinan, Philippines
Boehringer Ingelheim Investigational Site
Angeles City, Philippines
Boehringer Ingelheim Investigational Site
Angeles City, Pampanga, Philippines

Clareo Health | Clinical EvaluatioN of TElmisartan-based Antihypertensive Regimen